Details of the Drug
General Information of Drug (ID: DMSFHFL)
| Drug Name |
GSK-1108167A
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | GSK-167A; GSK-8055; Anthranilimide-based glycogen phosphorylase inhibitors (type 2 diabetes); Anthranilimide-based glycogen phosphorylase inhibitors (type 2 diabetes), GlaxoSmithKline | ||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Structure | 3D Structure is Not Available |
![]() |
|||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

